Ohio Public Employees Retirement System (OPERS)’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Buy
35,145
+8,626
+33% +$154K ﹤0.01% 1437
2026
Q1
$474K Buy
26,519
+19,698
+289% +$431K ﹤0.01% 1496
2025
Q4
$184K Sell
6,821
-176
-3% -$4.96K ﹤0.01% 1701
2025
Q3
$212K Buy
+6,997
New +$223K ﹤0.01% 1667

Other funds holding CAI

Ohio Public Employees Retirement System (OPERS)'s CAI Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Caris Life Sciences (CAI) stake by 33% in Q2 2026, buying an estimated $154K and bringing the position to 35,145 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Ohio Public Employees Retirement System (OPERS) first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 35,145 shares of Caris Life Sciences worth $626K as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 8,626 Caris Life Sciences shares in Q2 2026, an estimated $154K.
  • Caris Life Sciences made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1437 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.